Study Duration definition

Study Duration means an indication of the standard length of time it takes to complete a Programme, as set out in our postgraduate tuition fees pages on the University of Liverpool Online Programmes Website; Kaplan means ▇▇▇▇▇▇ Open Learning (Liverpool) Limited, an affiliate college of the University of Liverpool, incorporated and registered in England and Wales with company number 11979168, whose registered office is Palace House, ▇ ▇▇▇▇▇▇▇▇▇ ▇▇, ▇▇▇▇▇▇ ▇▇▇ ▇▇▇; Maximum Period of Registration means the maximum period in which your Programme must be completed. This can be found in our Code of Practice on Assessment; Net Tuition Fees means the tuition fees payable by you to study on your chosen Programme after deduction of approved discounts and/or scholarships (if any), as shown in your offer letter; Programme in these terms and conditions means a programme of study delivered online in partnership between the University and Kaplan, which leads to an award of the University; Start Date means the date on which the Programme you have accepted a place on commences; University means the University of Liverpool, an exempt charity, incorporated and registered in England and Wales as a Royal Charter Company with company number RC000660, whose address is the Foundation Building, ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇, Liverpool L69 7ZX; and
View Source
Study Duration. Adverse events will be collected for the duration of all studies. Study completion (closure) is defined as later of: - the last dose of the study medication, - the last visit by the subject or patient or, - the last subject or patient contact (e.g., phone contact) with the Investigator or designee as defined in the protocol. SAEs that occur within thirty (30) days after this closure must be reported. For survival studies, only deaths (not all serious AEs), that occur after the thirty (30) day period (study completion for each patient) need be reported.
View Source
Study Duration. Given two months for recruitment and with two study treatments provided 30 days apart, the anticipated study duration is six months. Table of Contents
View Source

Examples of Study Duration in a sentence

  • Study Start February 1, 2006 Work Stopped Due to FDA Request for Redesign **** Total Study Duration **** All service areas initiated start-up associated tasks until notice that the protocol required redesign.

  • If you take longer than the Indicative Study Duration to complete your Programme, there will be no additional fees charged and the maximum sum payable to Kaplan for your Programme will still be the Net Tuition Fees, subject to any increases outlined in section 5.5. If you are paying your Net Tuition Fees by monthly instalments, these will continue to be payable, even if you are on a study break, until the Net Tuition Fees have been paid.

  • The projected timeline for this Project is as follows: Develop and maintain **** Database **** months Total Study Duration **** months **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.

  • Clinical trial characteristics between 1999 and 2012 were analyzed based on Year Received, charting trends for Cost/Patient, Total Cost, Number of Patients, Study Duration, and Average Age.

  • Sites: 1 Anticipated Study Duration: 3 months Participant Duration: Single visit (1 day) The Collaboration Live Clinical Study is intended to evaluate the performance and safety of the Collaboration Live software in a clinical setting and will enroll 30 patients scheduled for routine OB/GYN ultrasound exams.

  • Study Duration: Subjects will be followed for at least two years following the vaccination.

  • Study Duration: Approximately eight (8) months Participant Duration: The study duration for each participant is up to approximately five (5) months (up to four [4] weeks for Screening, a single day of Treatment, and up to 16 weeks of Follow-up).

  • Study Duration 1 Year Assessment Tools Ankle Brachial Index HbA1c Monofilament test for neuropathy Photograph E-Z Graph Wound Assessment System Sf-36v2 Health Survey Primary Endpoint Proportion of subjects who have a closed wound at or before 12 weeks after the index procedure.

  • Vendor will implement security protocols consistent with those established in the Policy Manual and compliant with Privacy Laws for any Customer Information that comes under Vendor’s control.

  • DBA/CDA 1 study 3680 1.00 3,680 Data exports Assume 2 exports DBA 1 export 360 2.00 720 Database maintenance Study Duration = 18 months DBA 1 month 0 18.00 4,320 DM & Statistics - Project Management Client meetings & corresp, DM metrics.


More Definitions of Study Duration

Study Duration. The study will be conducted over 18 months (6-month recruitment period and 12-month treatment and follow up period).
View Source
Study Duration. The total study duration for [**].
View Source

Related to Study Duration

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Phase II Trial means a clinical trial of a Licensed Product, designated as a Phase II Trial and the principal purpose of which is to make a preliminary determination that such Licensed Product is safe and active in a patient population for its intended use and is designed to obtain sufficient information about such Licensed Product’s efficacy to permit the design of a Phase III Trial(s), and generally consistent with 21 CFR § 312.21(b). For purposes of this definition, Phase II trial shall specifically exclude expansion cohorts from Phase I Trial(s).

  • Study Completion means the database for the Study has been locked and all Essential Documents have been provided to the Sponsor, including a copy of the letter from the Reviewing HREC acknowledging receipt of the final report and/or closure letter from the Principal Investigator.

  • Phase III Clinical Study means a human clinical study of a product on a sufficient number of subjects that is designed to establish that such product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such product in the dosage range to be prescribed, which trial is intended to support Regulatory Approval of such product, as described in 21 C.F.R. 312.21(c). 1.185. [***] 1.186. [***]

  • Phase I Study means a human clinical trial in any country that would satisfy the requirements of 21 C.F.R. § 312.21(a) (FDCA), as amended from time to time, and the foreign equivalent thereof.